Dysregulation of T cells and B cells occurs in lupus and other autoimmune diseases. A monoclonal antibody therapy that seems to activate T cells restores some balance in a mouse model of lupus (pages 1405–1413).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sun, Y. et al. Therapeutic treatment of a spontaneous autoimmune disease with an agonistic monoclonal antibody against a costimulatory molecule. Nature Med. 8, 1405–1413 (2002).
Shlomchik, M.J., Craft, J.E. & Mamula, M.J. From T to B and back again: Positive feedback in systemic autoimmune disease. Nature Rev. Immunol. 1, 147–153 (2001).
Kammer, G.M., Perl, A., Richardson, B.C. & Tsokos, G.C. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum. 46, 1139–1154 (2002).
Oates, J.C. & Gilkeson, G.S. Mediators of injury in lupus nephritis. Curr. Opin. Rheumatol. 14, 498–503 (2002).
Sica, G. & Chen, L. Modulation of the immune response through 4-1BB. Adv. Exp. Med. Biol. 465, 355–362 (2000).
Ye, Z. et al. Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. Nature Med. 8, 343–348 (2002).
Halstead, E.S., Mueller, Y.M., Altman, J.D. & Katskikis, P.D. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nature Immunol. 3, 536–541 (2002).
Balomenos, D., Rumold, R. & Theofilopoulos, A.N. Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101, 364–371 (1998).
Nicoletti, F. et al. Dichotomic effects of IFN-γ on the development of systemic lupus erythematosus-like syndrome in MRL-lpr/lpr mice. Eur. J. Immunol. 30, 438–447 (2000).
Seo, S., Mandik-Nayak, L. & Erikson, J. B cell anergy and systemic lupus erythematosus. Curr. Dir. Autoimmun. 6, 1–20 (2003).
Gescuk, B.D. & Davis, J.C. Jr. Novel therapeutic agents for systemic lupus erythematosus. Curr. Opin. Rheumatol. 14, 515–521 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kammer, G. Immunotherapy tackles lupus. Nat Med 8, 1356–1358 (2002). https://doi.org/10.1038/nm1202-1356
Issue Date:
DOI: https://doi.org/10.1038/nm1202-1356